GOVX
GOVX
NASDAQ · Biotechnology

Geovax Labs Inc

$2.67
+0.09 (+3.49%)
As of Feb 8, 2:32 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +524.3% upside
Low Target $13.69
Average Target $16.67
High Target $25.88
Current Price $2.67
Current
$2.67
Target
$16.67
$13.69 $16.67 avg $25.88
Scenario Analysis
Bear Case
$13.69
412.7%
Low target
Base Case
$16.67
+524.3%
Avg target
Bull Case
$25.88
+869.3%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$21.15
-87.4% from high
52-Week Low
$12.82
+-79.2% from low
Target vs 52W High
$16.67
-21.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%